Cargando…
Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119231/ https://www.ncbi.nlm.nih.gov/pubmed/34859279 http://dx.doi.org/10.1007/s00198-021-06222-9 |
| _version_ | 1784710661198053376 |
|---|---|
| author | Nurmi-Lüthje, I. Tiihonen, R. Paattiniemi, E-L. Sarkkinen, H. Naboulsi, H. Pigg, S. Kaukonen, J-P. Kataja, M. Lüthje, P. |
| author_facet | Nurmi-Lüthje, I. Tiihonen, R. Paattiniemi, E-L. Sarkkinen, H. Naboulsi, H. Pigg, S. Kaukonen, J-P. Kataja, M. Lüthje, P. |
| author_sort | Nurmi-Lüthje, I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9119231 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer London |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91192312022-05-20 Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up Nurmi-Lüthje, I. Tiihonen, R. Paattiniemi, E-L. Sarkkinen, H. Naboulsi, H. Pigg, S. Kaukonen, J-P. Kataja, M. Lüthje, P. Osteoporos Int Correction Springer London 2021-12-03 2022 /pmc/articles/PMC9119231/ /pubmed/34859279 http://dx.doi.org/10.1007/s00198-021-06222-9 Text en © International Osteoporosis Foundation and National Osteoporosis Foundation 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Nurmi-Lüthje, I. Tiihonen, R. Paattiniemi, E-L. Sarkkinen, H. Naboulsi, H. Pigg, S. Kaukonen, J-P. Kataja, M. Lüthje, P. Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up |
| title | Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up |
| title_full | Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up |
| title_fullStr | Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up |
| title_full_unstemmed | Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up |
| title_short | Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up |
| title_sort | correction to: relatively low and moderate pre-fracture serum 25-hydroxyvitamin d levels associated with the highest survival in elderly hip fracture patients in finland: a minimum 3-year follow-up |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119231/ https://www.ncbi.nlm.nih.gov/pubmed/34859279 http://dx.doi.org/10.1007/s00198-021-06222-9 |
| work_keys_str_mv | AT nurmiluthjei correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT tiihonenr correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT paattiniemiel correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT sarkkinenh correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT naboulsih correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT piggs correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT kaukonenjp correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT katajam correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup AT luthjep correctiontorelativelylowandmoderateprefractureserum25hydroxyvitamindlevelsassociatedwiththehighestsurvivalinelderlyhipfracturepatientsinfinlandaminimum3yearfollowup |